Genoray Co., Ltd.
KKRX:1223103,115.00
KRW
-55.00
(-1.74%)
ISIN
KR7122310006
Return %
Stock
S&P 500
1Y
-38.92
14.39
3Y
-54.46
81.42
5Y
-68.21
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Byeong-Uk Park
- Full Time Employees
- 358
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Seongnam-si South Korea
- IPO Date
- May 28, 2018
- Website
- genoray.com
- Similar Companies
- Business
- Genoray Co., Ltd. is a South Korea-based medical device company that develops, manufactures, and markets diagnostic medical and dental digital X-ray imaging systems. Founded in 2001 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company operates across two principal business divisions: Medical Diagnostic Systems and Dental Imaging Systems. In its Medical division, the company manufactures and sells surgical mobile C-arm fluoroscopy systems, including the OSCAR 15, OSCAR Prime, ZEN-7000, and ZEN-2090 Pro series utilized in orthopedics, neurosurgery, pain management, and vascular interventions; full-field digital mammography systems, including the DMX-600 and MX-600 series for diagnostic breast screening; and portable diagnostic radiography units. In its Dental division, Genoray provides multi-functional cone beam computed tomography (CBCT) systems, including the Papaya 3D, Papaya 3D Plus, and Papaya 3D Premium lines that integrate 3D CBCT, panoramic, cephalometric, and model scanning capabilities; handheld and portable dental X-ray devices, including the Port-X IV and Port-X II series; intraoral digital X-ray sensors under the GIX-I brand; and proprietary clinical imaging and treatment planning software. The company supplies hospitals, specialized surgical centers, private dental practices, and veterinary clinics across more than 80 countries, supported by international subsidiaries including Genoray America Inc. in the United States, Genoray EU GmbH in Germany, Genoray Japan Co., Ltd. in Japan, Genoray Medical Equipment Co., Ltd. in China, and Genoray Medtech in Turkey. In recent operational developments, Genoray has accelerated the rollout of its next-generation flat-panel detector (FPD) surgical C-arm systems featuring low-dose fluoroscopy and artificial intelligence-assisted image reconstruction; expanded its presence in Western healthcare markets by securing European Medical Device Regulation (MDR) certifications and additional U.S. FDA 510(k) clearances for its advanced dental and medical product lines; strengthened its direct sales and maintenance networks in North America and Europe; and established strategic partnerships with digital dentistry software providers and medical original equipment manufacturer (OEM) partners to integrate AI-driven diagnostic workflows into its imaging platforms.